Urgent Public Health designation guidance notes
Urgent Public Health Designation
UPH Designation criteria
Your study will be assessed by the UPH Group and assessed against the following criteria:
- How compelling is the science underpinning the proposed study?
- Is it feasible to deliver in the current environment of the NHS and social care?
- Is the funding appropriate to deliver the proposed outcomes of the study?
- Is there an appropriate management plan to avoid interference with recruitment to other Urgent Public Health studies?
- Will results be known within 12 months of the start of the study?
UPH Designation process
Complete and submit the application form on the NIHR website and wait to hear if you have received UPH designation status (usually within 5 working days)
The Urgent Public Health portal no longer accepts part-funded or unfunded studies. Only fully funded studies will be considered for Urgent Public Health designation. Funding is required to be eligible for adoption onto the CRN Portfolio (see below).
UPH application submission
The submission of your UPH application can be made by either a Chief Investigator or a commercial company. Please ensure that the study is only submitted once.
The questions that will be asked during the submission process are:
Chief Investigator / Principal Investigator contact details and alternative contact details
IRAS number (if known)
Project Type (Interventional, Observations, Other)
Project summary to be made publicly available
Publicly available information (eg website)
Project Type (commercial, non-commercial, collaborative)
Name of sponsor
Has funding been obtained? Confirmation will be required
For non-commercial projects, please provide an estimate amount of the research costs for 20/21 (estimate only, non-binding value)
For non-commercial projects, please provide an estimate amount of research costs for 21/22 (estimate only, non-binding value)
Does the project / research require enrolment of patients with COVID-19
If this project / research requires enrolment of patients with COVID-19, in what setting will this take place?
Which UK nations will be or are intended to be project locations?
Does your study include drug therapy? If yes, what is the name, dosage, number of doses and sample size.
Do you have the drug in stock? If yes, please indicate how many doses and who is your supplier?
Does your study require viral swabs?
Do you have viral swabs in stock? If yes, please indicate how many? Who is your supplier?
Does your study require kits?
Do you have the kits in stock, if yes, indicate how many? Who is your supplier?
UPH Designation scope
Study cannot happen without CRN or additional NHS resources eg:
- Requires study specific patient consent
Out of scope
Study can happen without CRN or additional NHS resources eg:
- Data Science using anonymised and pseudonymised data
- Samples purchased from commercial organisations
- Samples from diagnostic archives
Studies that are out of scope may apply elsewhere for funding.
UPH Designated study amendments
Studies that are already underway need to be assessed by the Urgent Public Health Group if they require support from NIHR CRN for the amended protocol. Application for amendments can be submitted via the ‘short-form’ application process. Please email firstname.lastname@example.org for access to the form.
Eligibility for NIHR Clinical Research Network support
All studies, regardless of type, must:
- Meet the definition of research (as outlined in the Department of Health and Social Care Eligibility Criteria) as follows:
“Research can be defined as the attempt to derive generalisable or transferable new knowledge to answer or refine relevant questions with scientifically sound methods. This excludes: audit; needs assessments; quality improvement and other local service evaluations. It also excludes routine banking of biological samples or data except where this activity is integral to a self-contained research project designed to test a clear hypothesis.”
- Have appropriate ethical approval; and Health Research Authority (HRA) approval where required
#HRA Approval includes the provision of Schedule of Events Cost Attribution Tool (SoECAT) which has been authorised by the Lead CRN AcoRD Specialist
- Have full research funding (i.e. funding to meet all Research Costs in compliance with the AcoRD guidance) and outlined in a SoECAT completed with support from the Lead CRN AcoRD Specialist) from an eligible funding source.
Please also refer to full details on Eligibility for NIHR Clinical Research Network Support